 changes in
the velocity criterion caused by the stent itself, and standard
diagnostic criteria do not apply. Artifacts associated with
both CTA and MRA similarly limit the utility of these
techniques in the post-CAS patient. DSA is required to
confirm restenosis after CAS identified by CDUS when
reintervention is contemplated. In contrast, CDUS is sufficient to diagnose and plan therapy for restenosis after
CEA.
‚óè Recommendations for selection of